198 related articles for article (PubMed ID: 26680512)
1. Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.
Bhattacharya S; Hanpude P; Maiti TK
Sci Rep; 2015 Dec; 5():18462. PubMed ID: 26680512
[TBL] [Abstract][Full Text] [Related]
2. Familial and Somatic
Peng H; Prokop J; Karar J; Park K; Cao L; Harbour JW; Bowcock AM; Malkowicz SB; Cheung M; Testa JR; Rauscher FJ
Cancer Res; 2018 Mar; 78(5):1200-1213. PubMed ID: 29284740
[TBL] [Abstract][Full Text] [Related]
3. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
4. BAP1 Missense Mutations in Cancer: Friend or Foe?
Okonska A; Felley-Bosco E
Trends Cancer; 2019 Nov; 5(11):659-662. PubMed ID: 31735283
[TBL] [Abstract][Full Text] [Related]
5. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
[TBL] [Abstract][Full Text] [Related]
6. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD
J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997
[TBL] [Abstract][Full Text] [Related]
7. Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.
Peng H; Cassel J; McCracken DS; Prokop JW; Sementino E; Cheung M; Collop PR; Polo A; Joshi S; Mandell JP; Ayyanathan K; Hinds D; Malkowicz SB; Harbour JW; Bowcock AM; Salvino J; Kennedy EJ; Testa JR; Rauscher FJ
Mol Cancer Res; 2021 Jul; 19(7):1099-1112. PubMed ID: 33731362
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.
Puri S; Hsu SD
Biochem Biophys Res Commun; 2022 Apr; 599():57-62. PubMed ID: 35176625
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin recognition of BAP1: understanding its enzymatic function.
Hanpude P; Bhattacharya S; Kumar Singh A; Kanti Maiti T
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935764
[TBL] [Abstract][Full Text] [Related]
10. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Ventii KH; Devi NS; Friedrich KL; Chernova TA; Tighiouart M; Van Meir EG; Wilkinson KD
Cancer Res; 2008 Sep; 68(17):6953-62. PubMed ID: 18757409
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
Yu H; Mashtalir N; Daou S; Hammond-Martel I; Ross J; Sui G; Hart GW; Rauscher FJ; Drobetsky E; Milot E; Shi Y; Affar el B
Mol Cell Biol; 2010 Nov; 30(21):5071-85. PubMed ID: 20805357
[TBL] [Abstract][Full Text] [Related]
12. Roles of the BAP1 Tumor Suppressor in Cell Metabolism.
Han A; Purwin TJ; Aplin AE
Cancer Res; 2021 Jun; 81(11):2807-2814. PubMed ID: 33446574
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.
Xia YK; Zeng YR; Zhang ML; Liu P; Liu F; Zhang H; He CX; Sun YP; Zhang JY; Zhang C; Song L; Ding C; Tang YJ; Yang Z; Yang C; Wang P; Guan KL; Xiong Y; Ye D
Protein Cell; 2021 Jul; 12(7):557-577. PubMed ID: 32683582
[TBL] [Abstract][Full Text] [Related]
14. G-quadruplexes in the BAP1 promoter positively regulate its expression.
Li Y; Zhang X; Gao Y; Shi J; Tang L; Sui G
Exp Cell Res; 2018 Aug; 369(1):147-157. PubMed ID: 29787736
[TBL] [Abstract][Full Text] [Related]
15. Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma.
Mori T; Sumii M; Fujishima F; Ueno K; Emi M; Nagasaki M; Ishioka C; Chiba N
Cancer Sci; 2015 Sep; 106(9):1118-29. PubMed ID: 26081045
[TBL] [Abstract][Full Text] [Related]
16. BAP1 regulates IP3R3-mediated Ca
Bononi A; Giorgi C; Patergnani S; Larson D; Verbruggen K; Tanji M; Pellegrini L; Signorato V; Olivetto F; Pastorino S; Nasu M; Napolitano A; Gaudino G; Morris P; Sakamoto G; Ferris LK; Danese A; Raimondi A; Tacchetti C; Kuchay S; Pass HI; Affar EB; Yang H; Pinton P; Carbone M
Nature; 2017 Jun; 546(7659):549-553. PubMed ID: 28614305
[TBL] [Abstract][Full Text] [Related]
17. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
[TBL] [Abstract][Full Text] [Related]
18. Research Progress of BAP1 in Structure, Function, and Cancer.
Lu WT; Li MR; Yang YB; Sun YY; Dong CM
Protein Pept Lett; 2023; 30(7):552-561. PubMed ID: 37246324
[TBL] [Abstract][Full Text] [Related]
19. A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.
Parrotta R; Okonska A; Ronner M; Weder W; Stahel R; Penengo L; Felley-Bosco E
J Thorac Oncol; 2017 Aug; 12(8):1309-1319. PubMed ID: 28389374
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
